Authorized purpose: Adjunctive opportunistic detection and quantification of aortic valve calcification during routine clinical-care chest CT review; a physician reviews the informational ROI and estimated calcium burden and decides any further action.
Clinical role
Adjunctive, on-demand informational support for physician review; the output is not a stand-alone diagnostic decision and does not replace the original report or CT study.
Images and patients
CT/CTA · Heart/Cardiovascular
Key limitation
Keep in mind: The cleared population is adults aged 40 years and above with non-gated, non-contrast chest CT. The ROI and score are informational, results are not intended for stand-alone use, and physician review of the original report and CT remains required; performance outside the submitted study conditions was not established here.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Adjunctive opportunistic detection and quantification of aortic valve calcification during routine clinical-care chest CT review; a physician reviews the informational ROI and estimated calcium burden and decides any further action.
Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Heart/Cardiovascular Input: Adult non-gated, non-contrast chest CT images, received in DICOM format from compatible CT systems; the FDA comparison lists slice thickness up to 5 mm.
Who uses it?Intended users: Qualified medical professionals such as cardiologists or radiologists.
What does the software produce?Output: An informational circular ROI localizing detected aortic-valve calcium and an estimated Agatston-equivalent calcium score; the quantification can be viewed in the patient report and the ROI in a diagnostic image viewer.
What is its most important limitation?Key limitation: The cleared population is adults aged 40 years and above with non-gated, non-contrast chest CT. The ROI and score are informational, results are not intended for stand-alone use, and physician review of the original report and CT remains required; performance outside the submitted study conditions was not established here.
Clinical takeaway. Clinical role: Adjunctive opportunistic detection and quantification of aortic valve calcification during routine clinical-care chest CT review; a physician reviews the informational ROI and estimated calcium burden and decides any further action.
Evidence takeaway. Evidence from the reviewed source record: The FDA-described retrospective stand-alone validation used cases from 33 sites across three US geographic regions. Reported agreement bias was -5.15 AU with lower and upper limits of agreement of -200.96 AU and 190.65 AU; circular-ROI precision was 0.826 and recall was 0.855.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Adjunctive opportunistic detection and quantification of aortic valve calcification during routine clinical-care chest CT review; a physician reviews the informational ROI and estimated calcium burden and decides any further action.
Adjunctive, on-demand informational support for physician review; the output is not a stand-alone diagnostic decision and does not replace the original report or CT study.
Adult non-gated, non-contrast chest CT images, received in DICOM format from compatible CT systems; the FDA comparison lists slice thickness up to 5 mm.
An informational circular ROI localizing detected aortic-valve calcium and an estimated Agatston-equivalent calcium score; the quantification can be viewed in the patient report and the ROI in a diagnostic image viewer.
The cleared population is adults aged 40 years and above with non-gated, non-contrast chest CT. The ROI and score are informational, results are not intended for stand-alone use, and physician review of the original report and CT remains required; performance outside the submitted study conditions was not established here.
The FDA-described retrospective stand-alone validation used cases from 33 sites across three US geographic regions. Reported agreement bias was -5.15 AU with lower and upper limits of agreement of -200.96 AU and 190.65 AU; circular-ROI precision was 0.826 and recall was 0.855.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The FDA-described retrospective stand-alone validation used cases from 33 sites across three US geographic regions. Reported agreement bias was -5.15 AU with lower and upper limits of agreement of -200.96 AU and 190.65 AU; circular-ROI precision was 0.826 and recall was 0.855.
DesignRetrospective stand-alone validation with Bland-Altman agreement as the primary endpoint and circular-ROI precision and recall as secondary endpoints.
PopulationCases curated from 33 sites across three geographic regions in the United States; the reviewed FDA summary does not state the total number of cases.
Scopeexact submission
Tested versionBunkerhill AVC configuration submitted in K243229
Sites33
IndependenceSponsor or vendor study
K243229
This is an FDA submission validation study of localization and agreement against established ground truth, not an independent clinical-outcomes study.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-submission FDA recall query returned no native recall record for K243229. This limited result does not establish absence of recall or other safety information and does not cover later versions, family records, or adverse-event sources.
Public source
Exact FDA submission
Checked 2026-09-07
The local exact-ID recall packet contained zero records; this is a limited query result, not a safety clearance.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Adult non-gated, non-contrast chest CT images, received in DICOM format from compatible CT systems; the FDA comparison lists slice thickness up to 5 mm.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The SaMD interfaces with compatible commercially available CT systems and receives DICOM CT images; the result can be shown as a separate ROI series in a diagnostic viewer or as an estimated score in the patient report while the original study remains available.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The reviewed exact FDA summary and vendor announcement establish the CT/DICOM workflow but do not establish whether the current exact configuration is cloud, on-premises or hybrid.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-07 ·
Returned objects
Source context, not route validation: An informational circular ROI localizing detected aortic-valve calcium and an estimated Agatston-equivalent calcium score; the quantification can be viewed in the patient report and the ROI in a diagnostic image viewer.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: An informational circular ROI localizing detected aortic-valve calcium and an estimated Agatston-equivalent calcium score; the quantification can be viewed in the patient report and the ROI in a diagnostic image viewer.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The SaMD interfaces with compatible commercially available CT systems and receives DICOM CT images; the result can be shown as a separate ROI series in a diagnostic viewer or as an estimated score in the patient report while the original study remains available.
Bunkerhill Health's website states SOC 2 Type II certification, HIPAA compliance and ISO/IEC 27001:2022 certification. Badges only: no scope, dates or controls are given. Vendor-wide.
Vendor-wide
Checked 2026-10-25
Vendor statement, not an attestation; exact-release scope is not established.
The cleared workflow accepts non-gated, non-contrast chest CT in DICOM and makes an informational ROI available in a diagnostic viewer plus an estimated calcium score available in the patient report.
Bunkerhill describes AVC as an AI solution that detects and quantifies aortic valve calcification on non-gated, non-contrast chest CT and offers a health-system demo/contact path.
product family · checked 2026-09-08
Vendor announcement content is current buyer context; exact K243229 installation, hosting, security, price and support terms remain unestablished.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-07Last searched
20Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
Stored candidate metadata was screened; no PubMed or trial IDs were returned for this submission. This is metadata screening, not a full-paper or systematic literature review. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, vendor announcement, stored candidate metadata, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K243229 configuration was reviewed.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established. A general database search cannot prove coverage or noncoverage; verify payer, site of service, coding, and local payment assumptions.
Deployment: Not publicly available - checked 2026-09-07 - Exact FDA submission
The reviewed exact FDA summary and vendor announcement establish the CT/DICOM workflow but do not establish whether the current exact configuration is cloud, on-premises or hybrid.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-10-27 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: cvi42 Coronary Plaque supports qualified professionals with viewing, post-processing, and qualitative and quantitative evaluation of adult cardiac CT DICOM images to assess the presence and extent of coronary plaques and stenoses in CCTA for CAD or suspected CAD.
Authorized purpose: vascuCAP analyzes contrast multidetector CT of arterial vessels to support atherosclerosis stratification with color maps, three-dimensional views, multiplanar reformats, and measurements for physician review.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.